Topical PUVA therapy for chronic hand eczema

Area of Science:

• Dermatology
• Phototherapy

Background:

• Chronic hand eczema is a debilitating condition often resistant to conventional topical treatments.
• Limited treatment options exist for patients with persistent hand eczema.

Purpose of the Study:

• To evaluate the efficacy and safety of topical 8-methoxypsoralen and UVA (PUVA) for chronic hand eczema.

Main Methods:

• Seventeen patients with persistent chronic hand eczema received topical 0.1% 8-methoxypsoralen and UVA (PUVA) treatment for 8 weeks.
• Clinical response was assessed, and data on treatment duration, UVA dose, and patient factors were collected.

Main Results:

• Significant improvement was observed in 29% of patients, moderate improvement in 53%, and little improvement in 18%.
• No correlation was found between clinical response and eczema duration, positive patch tests, or atopic status.
• The mean treatment course involved 22.2 sessions with a mean total UVA dose of 63.5 J/cm2.

Conclusions:

• Topical PUVA therapy is an effective treatment for chronic hand eczema, demonstrating positive outcomes in all participants.
• The treatment is associated with no systemic side effects, positioning it as a safe alternative.
• Topical PUVA should be considered for patients with chronic hand eczema refractory to other topical therapies.